Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.21.2
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue, Major Customer [Line Items]        
Revenues $ 17,655,592 $ 10,321,754 $ 45,613,068 $ 30,842,874
FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 17,655,592 9,645,720 44,750,237 29,592,915
PREBOOST Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues   676,034 862,831 1,249,959
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 13,501,862 5,391,523 32,916,343 18,395,280
Global Public Health Sector [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues $ 4,153,730 $ 4,254,197 $ 11,833,894 $ 11,197,635